Browsing Tag
National Institutes of Health
16 posts
Fauci invokes Fifth Amendment as explosive Rand Paul COVID hearing ends in contempt threat
Fauci invoked the Fifth Amendment at a heated Senate COVID hearing as Rand Paul threatened contempt action over his refusal to testify.
Appili Therapeutics faces funding reset after NIAID terminates VXV-01 contract
Appili Therapeutics faces a funding reset after NIAID ended its VXV-01 contract. Discover what the termination means for APLI investors.
Alzheimer’s blood test breakthrough raises hopes for earlier dementia risk detection
Alzheimer’s may start long before memory loss. Blood tests could shift dementia care from late diagnosis to earlier risk planning.
Could SBS-147 become a credible challenger to opioid-based pain management pathways?
Could SBS-147 challenge opioid-based pain treatment pathways? Read how Sparian Biosciences’ Phase 1 launch could reshape the non-opioid market.
Trump proposes largest military budget in US history at $1.5tn for fiscal 2027
The White House has proposed $1.5 trillion in defense spending for fiscal 2027, the largest military budget request in US history, as the country remains at war with Iran.
Children’s Hospital of Philadelphia study uncovers missing RNA fragments as potential key to targeted immunotherapy for pediatric brain tumors
CHOP researchers discover that missing RNA microexons in pediatric brain tumors create a targetable NRCAM variant, opening new paths for safer immunotherapy.
Virpax Pharmaceuticals extends collaboration with NIH for pain management drug development
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a company focused on innovative pharmaceutical solutions for pain management, announced the extension…
Thermo Fisher Scientific and NCI launch myeloMATCH trial to advance AML and MDS treatment
In a significant advancement in cancer treatment, Thermo Fisher Scientific Inc. (NYSE: TMO) has partnered with the National…
RevBio secures NIH grant for game-changing TETRANITE Technology
RevBio, Inc., revealed that it has secured a substantial grant of up to $3.4 million, to be disbursed…
BITT secures NIH funding for pioneering Sjögren’s syndrome treatment
Boston Immune Technologies and Therapeutics, Inc. (BITT), a leading clinical-stage biotechnology firm specializing in tumor necrosis factor superfamily…